FDA Inspection
EMSL Analytical, Inc. dba MPL LaboratoriesEMSL Analytical, Inc. dba MPL Laboratories – FDA Inspection, May 21, 2026
Record Details
This FDA Inspection record concerns EMSL Analytical, Inc. dba MPL Laboratories, with an inspection on May 21, 2026, issued by the New Jersey District Office, covering human drugs.
View Company Profile
ID · 36c30a72-ec27-4b98-89d4-66650bb07c34
Inspection Facts
- Inspection number
- 1318220
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.165(e)Test methods
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 211.68(b)Computer control of master formula records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of EMSL Analytical, Inc. dba MPL Laboratories
6| Date | Classification | Office | Project area |
|---|---|---|---|
| January 12, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 3, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 5, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 9, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 18, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for EMSL Analytical, Inc. dba MPL Laboratories
- FDA Inspection 1227791 - 2024-01-12
- FDA Inspection 989130 - 2016-10-03
- FDA Inspection 894261 - 2014-09-05
- FDA Inspection 756470 - 2011-12-09
- FDA Inspection 611938 - 2009-09-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.